Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 avr. 2026 11h45 HE | Source: Eurobio Scientific

EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS

2025 ANNUAL RESULTS Annual revenue up 9% to €168 millionRoll-out of the Group’s strategy: Sales of proprietary products up 20%, accounting for 35% of revenueInternationalisation: 42% of revenue...
10 avr. 2026 08h42 HE | Source: SNS Insider pvt ltd

Longevity Market Size is Projected to Reach USD 67.03 Billion by 2035 Caused by the Increasing Number of Age-related Concerns Globally | SNS Insider

Longevity Market to reach USD 67.03B by 2035, driven by preventive care, AI innovations, and rising demand for personalized and regenerative therapies.
10 avr. 2026 08h30 HE | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+...
10 avr. 2026 08h30 HE | Source: FibroBiologics, Inc.

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

HOUSTON, April 10, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with...
10 avr. 2026 08h30 HE | Source: Annovis Bio Inc.

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission

Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28%...
10 avr. 2026 08h15 HE | Source: BCC Research LLC

Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate

Report provides in-depth insights into technological developments, pipeline trends, and global opportunities shaping the future of bispecific antibodies.
10 avr. 2026 07h14 HE | Source: Mordor Intelligence

Immunohistochemistry Market Led by Diagnostics Segment with 60%+ Share; Market Projected to Reach USD 4.42 billion by 2031, Mordor Intelligence Reports

Immunohistochemistry demand grows in oncology diagnostics and digital pathology as companies like Thermo Fisher, Roche, Agilent and Merck drive innovation.
10 avr. 2026 06h19 HE | Source: Research and Markets

1 Day Digital Chemistry, Manufacturing, and Controls (CMC) Training Course: Knowledge and Tools to Leverage Digital CMC As a Cornerstone of Pharma 4.0 (ONLINE EVENT: May 6, 2026)

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "Digital CMC (May 6, 2026)" training has been added to ResearchAndMarkets.com's offering.The pharmaceutical and biotech industries are under...
10 avr. 2026 06h03 HE | Source: Precedence Research

Precedence Research Brings Precedence Q: The Ultimate Platform for Real-Time Data, Analytics, and Market Statistics

Ottawa, April 10, 2026 (GLOBE NEWSWIRE) -- Precedence Research introduces Precedence Q, an advanced market intelligence platform designed to help investors and businesses capitalize on trends,...
10 avr. 2026 05h45 HE | Source: Research and Markets

Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision Medicine

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "Next-Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application - Global Forecast to 2030" has been added to ...

Page suivante